Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Original Article

Volume 5, Number 6, December 2014, pages 171-175

Interleukin 17A in Patients With Stable Coronary Artery Disease: Are There Differences According to Gender?

Tables

Table 1. Clinical Characteristics of the Patients
 
ComorbiditiesMen (24 patients)Women (16 patients)P
Hypertension, n (%)14 (59%)8 (50%)0.8
Dyslipidemia, n (%)11 (45.8%)8 (50%)0.9
Diabetes mellitus, n (%)6 (25%)9 (56.2%)0.09
Smoking, n (%)4 (16.6%)3 (18.7%)0.7
Peripheral artery disease, n (%)2 (8.3%)3 (18.7%)0.6
Stroke, n (%)1 (4.1%)1 (6.2%)0.6
Chronic kidney disease, n (%)1 (4.1%)1 (6.2%)0.6

 

Table 2. Interleukin 17A in Male Patients and Male Controls
 
MenP
PatientsControls
Median (Min - Max)Median (Min - Max)
IL17A: interleukin 17A; CCWS: after 48 h of cell culture without stimulation; CCS: after 48 h of cell culture with stimulation.
IL17ASerum3.91 (3.91 - 3.91)3.91 (3.91- 9.28)0.31
CCWS3.91 (3.91 - 3.91)3.91 (3.91 - 3.91)0.45
CCS451.67 (99.02 - 892.58)135 (3.91 - 285)0.04

 

Table 3. Interleukin 17A in Female Patients and Female Controls
 
WomenP
PatientsControls
Median (Min - Max)Median (Min - Max)
IL17A: interleukin 17A; CCWS: after 48 h of cell culture without stimulation; CCS: after 48 h of cell culture with stimulation.
IL17ASerum3.91 (3.91 - 3.91)3.91 (3.91 - 625)0.90
CCWS3.91 (3.91 - 3.91)3.91 (3.91 - 3.91)0.20
CCS131.21 (3.91 - 231.97)173.78 (3.91 - 642)0.24

 

Table 4. Interleukin 17A in Male Patients and Female Patients
 
PatientsP
MenWomen
Median (Min - Max)Median (Min - Max)
IL17A: interleukin 17A; CCWS: after 48 h of cell culture without stimulation; CCS: after 48 h of cell culture with stimulation.
IL17ASerum3.91 (3.91- 3.91)3.91 (3.91 - 3.91)0.17
CCWS3.91 (3.91 - 3.91)3.91 (3.91 - 3.91)0.47
CCS451.67 (99.02 - 892.58)131.21 (3.91 - 231.97)0.02